RECALL DATABASE

Lidocaine Ointment Recall: Sun Pharma TarO Speermint 5% 50 g Jar

Announced 2026-09-23 · FDA

FDA recalls Lidocaine Ointment USP, 5%, Speermint flavor, 50 g jar (Rx only) manufactured by TarO Sun Pharma. The recall is due to failed content uniformity specifications and out-of-spec assay at the 24-month long-term stability test at 25°C/60% RH. A total of 65,328 jars distributed nationwide in the USA are included in Lot AD48154, Exp 4/30/2027.

BrandSUN PHARMA /TARO
ProductLidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5
ReasonFailed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Severitymoderate
Units affected65328
DistributionNationwide in the USA
AgencyFDA

WHAT YOU SHOULD DO

  1. If you have Lot AD48154, stop using the product and discard or return it to the place of purchase.
  2. Check your other products for the same lot number and do not use any that match Lot AD48154.
  3. If you have used this product and have health concerns, contact your healthcare provider for advice.

How to identify the recalled item

Lot / date codesLot # AD48154, Exp: 4/30/2027.
Lot / date codesLot # AD48154, Exp: 4/30/2027.

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other SUN PHARMA /TARO recalls

See all SUN PHARMA /TARO recalls →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.